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 Chapter 17 
 Dendritic Cells 
 Maud  Plantinga ,  Colin  de  Haar , and  Stefan  Nierkens 
 Abstract  Dendritic cells (DCs) are the sentinels of the immune system and play a 
critical role in stimulating immune responses against pathogens and maintaining 
immune homeostasis to harmless antigens. They can be found in all lymphoid and 
most non-lymphoid tissues, including mucosal surfaces, like the lung and the gut, 
where intricate networks of DCs are situated to sense potential harmful exposures. 
As such, DCs are among the fi rst cells to come into contact with food bioactives in 
the gastrointestinal tract and thus are instrumental in shaping the immune system’s 
response to such exposures. Here we provide an overview of DC characteristics, 
with the emphasis on DCs in the mucosal immune system, and discuss in vitro/ex 
vivo DC culture settings that can be applied for in vitro testing of (food) 
compounds. 
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17.1  Origin 
 Paul Langerhans was the fi rst to describe DCs in the nineteenth century, when he 
visualised dendritically shaped cells in the skin (Langerhans  1868 ). Ralph 
M. Steinman and Zanvil A. Cohn identifi ed “dendritic cells” as a specifi c group of 
white blood cells (Steinman and Cohn  1973 ), and it was not until 1998 that the 
central role of DCs as professional antigen presenting cells for the induction of 
adaptive immunity was defi ned (Banchereau and Steinman  1998 ). Over the last few 
decades the DC-fi eld has developed extensively with enhanced knowledge on DC 
progenitors, distinctive subsets, and their specifi c functions depending on the tissues 
where they reside. 
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17.2  Features and Mechanisms 
 DCs continuously sample antigens from their environment by phagocytosis, 
receptor- mediated endocytosis, and pinocytosis. After uptake of antigens, DCs 
migrate to the draining lymph node. During migration they may mature and upregu-
late co-stimulatory molecules like CD40 and CD86, depending on the maturation 
signals they have encountered. DCs are equipped with unique pattern recognition 
receptors (PRRs) for which the ligands may activate or inhibit DC maturation and 
facilitate antigen recognition, uptake and processing. The extensive sets of PRRs 
(e.g. Toll-like receptors (TLRs), C-type lectins (CLRs), Nod-like receptors (NLRs) 
and Retinoic acid induced gene-based (RIG)-I like receptors (RLRs)) are expressed 
on the cell surface or in intracellular compartments, like endosomes or in the cyto-
plasm to enable recognition of intra- and extracellular exposures. 
 Dendritic cells are instrumental for the activation of naïve T cells or reactivation 
of T cells from the memory pool (McLellan et al.  1996 ). T cell activation requires 
antigen presentation in MHC class I (for CD8 + T cell) or II (for CD4 + T cells) 
molecules (signal 1), in combination with expression of co-stimulatory molecules 
(signal 2). Cytokines provide a third signal and induce T cell differentiation and 
effector functions. Depending on the cytokine environment provided by DCs, CD4 + 
T cells differentiate into Thelper1 (Th1) via IL-12, Th2 via IL-4, or Th17 cells via 
IL-6 (Kapsenberg  2003 ; Bettelli et al.  2008 ). In addition, Th cells can also differen-
tiate into regulatory phenotypes (Tregs, Th3 and Tr1) that dampen immune responses 
(Sakaguchi et al.  2006 ). On the other hand, DCs instruct CD8 + T cells, which rec-
ognize MHC class I (cross)presented antigens, to develop into cytotoxic lympho-
cytes (CTLs) (Bhardwaj et al.  1994 ). 
 The responsiveness of DCs in terms of expression of co-stimulatory/regulatory 
molecules and cytokine profi les may thus provide insight into the immune modulat-
ing properties of food bioactives. Here, we provide an overview of the different DC 
subsets in blood, and more specifi cally in the gastrointestinal tract (Fig.  17.1 ). Then 
we will provide information on the in vitro and ex vivo possibilities to study effects 
of food bioactives on DCs. 
17.2.1  DC Subsets 
 To study immune modulatory effect of bioactives on DCs, different models systems 
may be considered, e.g. DC cell lines, in vitro-generated DCs, or directly isolated 
primary DCs, each with their own advantages and disadvantages. It is important to 
realize that different subsets of DCs exist in peripheral blood and (non)lymphoid 
tissues and that the differentiation and function of each of these subsets is highly 
dependent on the interacting cells and mediators in the local microenvironment. 
So, while this chapter provides experimental settings to study the direct effects of 
food bioactives on DCs, one should always consider the possible indirect effect via 
stimulation of the bioactives on for instance epithelial cells, and that different DC 
subsets may respond differently to the same exposure. 
M. Plantinga et al.
183
17.2.1.1  Blood DCs 
 DCs can be divided in conventional DCs (cDCs) and plasmacytoid DCs (pDCs). 
In human blood, both cDCs and pDCs can be phenotypically characterized by the 
lack of lineage marker expression (CD3, CD14, CD19, CD56) and a high expres-
sion of HLA-DR. The circulating cDCs are CD11c + and are divided by the expres-
sion of CD1c (BDCA1) or CD141 (BDCA3). Human pDCs lack expression of 
CD11c and are discriminated by the expression of BDCA2, BDCA4 and/or CD123. 
CD16 + MHC class II + cells cluster as a distinct population in the blood (Lindstedt 
et al.  2005 ) and have previously been associated with DC origins by some. However, 
CD16 + cells were recently assigned to the monocyte lineage (Robbins et al.  2008 ; 
Ziegler-Heitbrock et al.  2010 ), confi rmed by transcript profi ling comparing CD16 + 
cells with BDCA1 + DCs (Frankenberger et al.  2012 ). 
17.2.1.2  Mucosal DCs 
 The mucosal immune system is highly specialized: it has to be able to avoid inva-
sion of (commensal) bacteria, and tolerate their presence in the intestine. It should 
also induce tolerance to non-harmful food antigens and protect against potentially 
harmful pathogens, toxins and xenobiotics. All of this takes place over a single layer 
of highly specialized epithelial cells (Chapter  2 ). 





 The formulation of antigens determines the main site for antigen uptake in the 
intestinal tract. Considerable evidence suggests that the gut associated lymphoid 
tissues (GALT), such as Peyers Patches (PP) and isolated lymphoid follicles, are 
critical for handling of particulate antigens. The microfold cells (M cells), present 
in the GALT epithelium, are involved in actively transferring the particulate anti-
gens from the gut lumen into the lymphoid areas. The role for GALT in the induc-
tion of oral tolerance to soluble antigens is not entirely clear. Normal oral tolerance 
could be induced in mice lacking PP. It was therefore suggested that the main func-
tion of the GALT is to control immune responses to commensal bacteria. Antigen 
uptake by DCs underlying the villus epithelium of the lamina propria (LP) in the 
small intestine has been shown to be crucial for induction of oral tolerance to solu-
ble antigens. How the DCs are provided with the antigens over the epithelial barrier 
will strongly depend on the compound and is beyond the scope of this chapter. 
Since both the intestinal tract and its draining lymph nodes contain specifi c DC 
subsets we will briefl y discuss them before providing detailed information of pos-
sible DC systems that could be used to mimic these DCs. 
 Intestinal DCs : Thorough comparative transcriptional and functional profi ling in 
DCs isolated from a human and murine small intestine LP and peripheral blood 
showed three DC subsets within the CD45 + lin − MHCII + LP population based on the 
expression of CD103 and Sirpα (Watchmaker et al.  2014 ). The CD103 + Sirpα − DCs 
(SP) were related to human blood BDCA3 + DCs, whereas CD103 + Sirpα + (DP) DCs 
expressed CD11b, CD207 (Langerin), CD209 and high levels of RALDH (coincid-
ing with human blood CD1c + DCs) and supported the induction of (FoxP3 + ) regula-
tory T cells. The CD103 − Sirpa + expressed CX3CR1, but lacked CD64 expression, 
and clustered with human monocytes indicating that they may have developed from 
monocytes recruited in response to gut infl ammation. Most of these cells are located 
deeper into the LP when compared to the network of phagocytic cells that is located 
right beneath the epithelial cells. These phagocytic cells express CD45, HLA-DR, 
CD14, CD64 and high levels of CX3CR1, and since these cells also do not migrate 
to the lymph nodes, they have been depicted as intestinal macrophages (Rivollier 
et al.  2012 ; Bain et al.  2012 ; Tamoutounour et al.  2012 ; Mann et al.  2013 ). 
 Mesenteric lymph node DCs : Soluble food bioactives may also be directly available 
for internalization by DCs in the draining lymph nodes via the conduit system 
(Gretz et al.  1997 ; Anderson and Shaw  2005 ; Sixt et al.  2005 ; Roozendaal et al. 
 2009 ). The mesenteric lymph node DCs are a mixture of cells found in peripheral 
blood as well as the LP. As such, peripheral blood DCs and their CD34-derived 
counterparts could represent these lymph node DCs. 
17.2.1.3  Monocyte-Derived DCs 
 Monocyte-derived (mo)DCs are rare under steady-state conditions in both blood and 
peripheral tissues. They can be found in increased numbers in vivo under infl amma-
tory conditions. The ability to culture moDCs from monocytes boosted their 
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popularity as a model to study human DC biology (Sallusto and Lanzavecchia 
 1994 ). The gene profi le of in vitro-generated MoDCs is enriched for genes also 
found in in vivo occurring moDC (Segura et al.  2013 ) and also emphasizes the 
monocyte origin (not DC origin) with acquired DC features. 
17.3  General Protocols 
 Primary DCs can be isolated from blood, and lymphoid or peripheral tissues, but the 
presence of DCs in blood is scarce and they are diffi cult to obtain in suffi cient numbers 
from tissues. In addition, one may encounter large donor variations. The use of cell 
lines would overcome these challenges, but may hold insuffi cient similarity with pri-
mary DCs with respect to their response to environmental stimuli, ability to capture 
antigens, mature, migrate, produce cytokines, present antigens and activate T cells. 
Here we summarize a series of commonly used functional DC assays below and 
discuss the performance of cell lines and primary cells (summarized in Table  17.2 ). 
17.3.1  DC Cell Lines 
 Most DC cell lines were differentiated from leukemia-derived cells, originating from 
myelogenous or monocytic lineage: the cytokine independent cell lines THP- 1, U937, 
KG-1, HL-60 and the cytokine dependent cell line Mutz-3 are the most commonly 
used (Table  17.1 ) (Berges et al.  2005 ; van Helden et al.  2008 ; Santegoets et al.  2008 ). 
The use of these lines has the advantage of the availability of large numbers of synchro-
nized cells with a long life span, but the association with selective DC subsets in 
peripheral blood and mucosal surfaces is largely unclear. All of these cells are leuke-
mic, representing DC precursor stages and may often need the addition of specifi c 
growth and differentiation factors to induce at least some characteristics of differenti-
ated DCs. MUTZ-3 is suggested to have the highest DC differentiation capacity 
(Santegoets et al.  2008 ) and may therefore be most representative for in vivo DCs.
 Table 17.1  DC cell lines 
 Cell line  Derived from 
 DC 
differentiation 
 T cell 
activation 
capacity  References 
 THP-1  Monoblastic leukemia cell line  Low  Yes  Tsuchiya et al. 
( 1980 ) Chap.  14 
 U937  Monocytic leukemia cells  Moderate  Yes  Chapter  15 
 KG-1  CD34 myelomonocytic cell line  Incomplete  Yes  Koeffl er et al. ( 1981 ) 
 HL-60  Acute pro-myelocytic leukemia 
cell line 
 Moderate  Yes  Koski et al. ( 1999 ) 
 MUTZ-3  Myeloid leukemia cell line  Relatively high  ?  Hu et al. ( 1996 ) 
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17.3.2  Isolating Primary DCs from Blood 
 DCs can be directly isolated from PB using their unique surface markers (Fig.  17.1 ) 
and utilizing either magnetic bead separation or fl ow cytometric cell sorting (Vremec 
and Shortman  1997 ; Dzionek et al.  2000 ; Shortman and Liu  2002 ). Since the per-
centage of DCs in PB is generally low (cDC: 0.6 % and pDC 0.2 % of all PBMC), 
DC-enrichment (by depletion of cells expressing lineage markers CD3, CD14, 
CD16, CD19, CD20, and CD56) is often used. For magnetic bead sorting, separa-
tion/isolation kits are commercially available from companies such as Miltenyi 
Biotec and StemCell Technologies. Preferably, freshly isolated PBMCs obtained by 
a density gradient of Ficoll-Hypaque, are suspended in cell isolation buffer as per 
manufacturer’s instructions. To optimize survival of primary DCs after isolation it 
may be helpful to add survival factors to the culture medium: 800 U/ml GM-CSF 
for cDCs, like CD1c or CD141 DCs, or 10 ng/ml IL-3 for pDCs. 
 Culturing peripheral blood-derived CD1c (BDCA1) DCs for 2 days with 
GM-CSF, vitamin D and Retinoic Acid (RA) induced high expression of RALDH 
as well as the ability to induce gut-homing receptors resembling the gut-resident 
CD103 + Sirpα + (DP) DCs to some extent (Sato et al.  2013 ). 
 Although using primary DCs directly isolated from the blood is feasible for most 
academic research labs and will probably resemble the in vivo DC biology most 
closely, the limited amount of primary DCs in PB is an obvious obstacle when many 
conditions and functional effects need to be assessed. 
17.3.3  CD34 + -Derived DCs 
 Another alternative is to generate DCs from myeloid precursors. CD34 is a marker 
expressed on haematopoietic stem cells and early myeloid progenitors that contain 
high proliferative potential. The CD34 + cells can therefore fi rst be expanded followed 
by a differentiation towards DCs. CD34 + cells can be isolated from bone marrow 
(BM), peripheral blood (PB) or from umbilical cord blood (CB) using magnetic 
labelling (Kato and Radbruch  1993 ). 
 Firstly, CD34 + cells can be expanded using different combinations of cytokines 
and growth factors. Flt-3L, TPO, SCF, IL-3, and IL-6 are early-acting cytokines that 
support the proliferation of DC precursors from CD34 + HPC. Two different cock-
tails, Flt3-L, TPO, SCF and Flt3-L, SCF, IL-3, IL-6 (FS36), were compared for their 
capacity to induce proliferation of CD34 + HPC (Bontkes  2002 ). FS36 showed the 
greatest ability to expand the CD34 + HPCs. Expanded CD34 + cells can be differen-
tiated towards different DC subtypes i.e. BDCA3 + DCs up to only 3 % (Poulin et al. 
 2010 ), or pDCs up to 5 % (Demoulin et al.  2012 ). Addition of TGF-beta during 
differentiation enhances the formation of langerin + LC (Soulas et al.  2006 ; Caux et al. 
 1992 ; Szabolcs et al.  1995 ). 
 Established protocols to culture LCs, dermal DCs, BDCA3 + DCs and pDCs can 
be found in literature and are summarized below (Fig.  17.2 ). 
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17.3.4  Monocyte-Derived DCs 
 Monocytes can be selected via adherence or CD14 + isolation with magnetic beads. 
For adherence, PBMCs are resuspended in culture medium and placed in a humidifi ed 
incubator maintained at 37 °C and 5 % CO 2 , to allow the monocyte precursors to 
adhere. After 1 h, non-adherent cells are simply removed by fi rmly tapping the fl ask 
and isolating non-adherent cells. For bead selection, PBMCs are resuspended in cell 
isolation buffer as per manufacturer’s instructions, followed by isolation using a 
 commercially available kit. The isolated monocytes can be frozen for later use. 
 Once the monocytes are selected, they can be differentiated towards DCs with 
culture-medium (e.g. X-vivo) supplemented with 800–1,000 U/ml GM-CSF and 
300–500 U/ml IL-4 (37 °C and 5 % CO 2 ) for 7 days. After the 6/7-day culture 
period, the immature DCs can be used for testing the immune modulatory effects of 
food bioactives. 
 To generate mucosal CD103 + Sirpα + (DP) resembling moDCs, RA, the even more 
potent RARalpha agonist AM580 or TGFbeta, can be added to the culture (Hartog 
et al.  2013 ; Martin et al.  2014 ). RA-induced moDCs express CD103 and can induce 
increased percentages of FoxP3 + in allogeneic CD4 + cells. RA-induced moDC also 
express high levels of IL-22BP which is comparable to the CD11b + CD103 + DCs 
found in mouse LP and MLN (Martin et al.  2014 ). 




17.4  Asses Viability 
 To validate the generation of DCs in these cultures, the purity of DCs can be assessed 
by fl ow cytometric analysis of the surface markers CD11c and HLA-DR. This stain-
ing can be expanded with markers, depending on the specifi c protocol used (for 
instance CD14 expression on MoDC or CD1c on CD34-derived DC.) Viability can 
be checked by adding a viability dye (e.g. 7AAD) to the FACS panel, or count the 
amount of cells with Tryphan blue with a microscope (Table  17.2 ).
17.5  Experimental Readout 
 Although bioactive food components have been shown to interact with many 
 different types of cells, it remains a legitimate question whether DCs exposed to 
food bioactives may in turn affect features of the innate or adaptive immune system, 
in particular T cells. Some food bioactives may be associated with the development 
of allergic or autoimmune-like clinical symptoms in susceptible individuals. 
The clinical manifestation, ranging from mild to severe and life-threatening, vary 
considerably for different compounds and for the same compound in different sub-
jects and may be idiosyncratic in nature. They comprise pseudo-allergic reactions 
(interference with immunological effector mechanisms and cells, such as mast 
cells), compound- allergic reactions (activation of compound-specifi c T and B cells), 
 Table 17.2  Summary of (dis)advantages of using differentially generated DCs 
 Type of DCs  Advantages  Disadvantages 
 Cell lines 
( THP - 1 ,  U937 , 
 KG - 1 ,  HL - 60 ) 
 Large number of cells. 
 Relatively long life span. 
 Association to primary DCs unclear 
(different stages of differentiation, 
discrepancies in DC-functions) 
 Primary DCs 
 CD1c  Largely comparable to in vivo 
counterpart. 
 CD1c can be treated to 
differentiate into gut-like DCs. 
 Low cell numbers. 
 Isolation procedures might affect 
phenotype and function. 
 BDCA3 
 pDCs 
 CD34 - derived DCs 
 Dermal DCs/
LCs 
 CD34 + cells can be expanded to 
increase cell number. 
 Resemble primary DCs very well. 
 Acquisition requires specialized centres. 
 % of pDC and BDCA3 DC are still low 
in these cultures, thus requiring large 
numbers of cells for selection. 
 pDCs 
 BDCA3 
 Monocyte - derived DCs 
 Large number of cells. 
 Relatively easy to obtain and 
culture. 
 Very well studied: extensive set of 
data available. 
 Represent infl ammatory monocytes 
with DC-features, which may hamper 
translation for primary DCs. 
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and compound-induced autoimmune reactions. Although the induction of allergic 
or autoimmune responses requires DC activation, food bioactives may also inhibit 
DC activation. This may represent an advantageous effect of food bioactives in 
reducing (chronic) infl ammatory response like asthma, infl ammatory bowel dis-
ease, etcetera, by reducing the DC activity and possibly inducing regulatory T cells. 
 Different assays can be performed to test the DC’s responsiveness to bioactives 
for the prediction of the subsequent immune modulatory effect of that specifi c com-
pound. These assays include the monitoring of phenotypic markers expressed on the 
surface of DCs indicating their differentiation, activation and their potentially stim-
ulating effect on T cells. Nevertheless, even with a clear outcome of these assays, it 
remains to be seen whether indeed antigen-specifi c T cells with the potential to 
induce adverse effects in vivo will be induced. In this regards it is important to con-
sider whether the food bioactive contains potential antigens, are able to form neo- 
antigens or merely function as adjuvants for responses against other components in 
the food or play a role in sensitization to auto-antigens. 
17.5.1  Co-stimulation 
 DCs may undergo a number of phenotypical changes, following maturation by the 
uptake and processing of an antigen. The process of DC maturation, in general, 
involves an increase in the surface expression of co-stimulatory molecules, like CD40, 
CD80, CD83, and CD86, which can be measured by fl ow cytometry. As a negative 
control unloaded DCs can be taken along, as well as a DC positively stimulated with 
a known maturation cocktail, like IL-1beta, IL-6, TNF and PGE-2 or TLR ligands. 
17.5.2  Cytokine Production 
 Besides up-regulation of co-stimulatory molecules, DCs produce a large variety of 
cytokines that could be either pro/anti-infl ammatory or skew the phenotype of T cells. 
Therefore, a quite simple procedure to test the activity of the DCs towards the food 
bioactives is the measurement of cytokine levels. A wide variety of cytokines may 
be expressed by mature DCs including IL-1 alpha, IL-1 beta, IL-4, IL-6, IL-8, IL-10, 
IL-12, IL-15, IL-16, IL-17, IL-18, IFN-alpha, IFN-beta, IFN-gamma, and TNF. These 
cytokines can be measured by ELISA, or multiplex assays. 
17.5.3  Other DC Readouts 
 Co-stimulation and cytokine production are effect parameters used in the vast 
majority of studies on effects of food bioactives on DCs (see Table  17.3 for an 
overview). Studying the induction of specifi c T cells is complicated due to the low 
17 Dendritic Cells
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frequency of T cell precursors with the corresponding TCR and requires extensive 
culture conditions and broad read-out tools as the TCR specifi city in these condi-
tions is unknown. With regard to the T cell stimulatory  potential of DCs the mixed 
lymphocyte reaction (MLR), in which DCs are used to stimulate alloreactive (naïve) 
T cells, can be considered. Proliferation in combination with cytokine production 
can be used as a read-out for T cell skewing.
17.6  In Vitro Studies on Food Bioactives Using DCs 
(Table  17.3 ) 
 The immunomodulatory effects of food bioactives can be broadly divided in ‘activa-
tion’, ‘suppression’ or ‘no detectable effect’. Table  17.3 shows that with regard to 
food proteins immune activation is generally the anticipated endpoint. It should 
however be considered that other food constituents instead of the protein itself, may 
stimulate DCs to internalize and present food proteins, and therefore may be 
involved in the risk for hypersensitivity. Immune suppression in DCs assays is 
mostly studied in combination with a trigger known to activate the DCs (TLR 
ligands i.e. LPS, CT or CD40 ligation). Inhibition of DC activation has been studied 
using probiotics, vitamins, polyphenols (Del Cornò et al.  2014a ), isofl avones and 
curcuminoids. Inhibition of DC activation may be relevant for people suffering from 
chronic infl ammation not only by reducing infl ammation directly but also by pre-
venting the risk for developing cancer, which is associated with chronic infl amma-
tion. Potential harmful effects of non-specifi c immune suppression include an 
increased risk of infection and also here the development of cancer. When there is 
no direct effect of the food bioactives on the DCs with the assays mentioned above, 
this does not mean that exposure to the compound is without risk. Indirect effects of 
the bioactives through their effects on other cells or the effects of their metabolites 
must be taken into consideration. 
17.7  Critical Notes 
 Extensive comparative studies using different DC assays with proven immune 
active compounds and food bioactive compound are lacking. 
 With regard to some of the DC parameters used to study immune modulatory 
effects of food bioactives, the expression of co-inhibitory molecules (e.g. PDL1 
and PDL2) has not been intensively studied. This family of molecules has however 
a large impact on the immune response and may therefore also be considered in 
future testing. 
 As mentioned before, the DCs are the sentinels of the immune system that gather 
not only by taking up or sensing the food bioactives only, but continuously receive 
input from cells and factors in their microenvironment. Potential responses should 
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therefore be evaluated in the light of the local environment. For instance, the choice 
for a particular DC model/subset may be dependent on the availability of certain 
compounds/entry site, which may relate to the size, solubility and formulation of 
the compound of interest. 
 In conclusion, studying the effects of food bioactives on DC (subsets) is an 
important step in addressing the immune modulating potential of these compounds 
in vivo, but should be part of a more extended monitoring program involving studies 
on the compound’s availability, factors of the microenvironment, and effects of 
metabolites/neo-epitopes. 
 Open Access This chapter is distributed under the terms of the Creative Commons Attribution 
Noncommercial License, which permits any noncommercial use, distribution, and reproduction in 
any medium, provided the original author(s) and source are credited. 
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